Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 10:23:81-91.
doi: 10.17179/excli2023-6700. eCollection 2024.

Empowering personalized medicine: unleashing the potential of patient-derived explants in clinical practice

Affiliations

Empowering personalized medicine: unleashing the potential of patient-derived explants in clinical practice

Oliwia Piwocka et al. EXCLI J. .

Abstract

In recent decades, significant progress has been made in understanding the molecular characteristics of cancer and its microenvironment, leading to the development of life-saving treatments. However, patients often experience side effects from standard therapies, highlighting the need for personalized medicine. Personalized medicine aims to customize drug therapy and preventive care based on individual patients' specific requirements. The heterogeneity within tumors and among patients necessitates personalized medicine approaches. Patient-derived organoids (PDOs), xenografts (PDXs), and explants (PDEs) have emerged as valuable models for studying tumor behaviour and drug response. This paper aims to summarize the latest advancements in patient-derived explants, focusing on their potential utility in the clinic. Different methods for culturing PDEs, including the free-floating approach, the grid method, and sponge scaffolds, are discussed. These approaches provide opportunities for long-term viability, oxygen and nutrient supply, and maintenance of tissue integrity. Additionally, various solid tumor models using PDEs are highlighted, together with assays to study PDE viability, characteristics, and response to drug treatment.

Keywords: individual therapy; oncology; patient-derived explants; personalized medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Table 1
Table 1. A summary of available methods of PDE culture, including their characteristic features, advantages and drawbacks. Choosing the most suitable method for patient-derived explant culture will depend on the specific research objectives, the cultured tissue type, and the desired level of experimental control and tissue preservation. Researchers often tailor their approach to achieve optimal study outcomes based on these factors.
Table 2
Table 2. PDE culture models, methods and their application in some solid tumors
Figure 1
Figure 1. Three types of PDE models. A) Tissue fragments are entirely submerged in a medium and float freely, often combined with rotation on a shaker; B) Specimens are cultured on a metal grid, having contact with a medium and air, culture of tissue slices or cubes; C) Tissue fragments are placed on the sponge scaffold to provide simultaneous nutrient and oxygen supply. Figure created with BioRender.
Figure 2
Figure 2. Applications of PDE models in research. Explants are the most commonly used in cancer research to test and validate various therapies considering personalized approach and tumor heterogeneity. PDEs are also valuable in biomarker discovery associated with different diseases, often leading to new drug development. Moreover, due to their unique properties, PDEs are bridging the gap between research and clinics.

Similar articles

Cited by

References

    1. Abreu S, Silva F, Mendes R, Mendes TF, Teixeira M, Santo VE, et al. Patient‑derived ovarian cancer explants: preserved viability and histopathological features in long‑term agitation‑based cultures. Sci Rep. 2020;10:19462. - PMC - PubMed
    1. Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30:R921–5. - PMC - PubMed
    1. Bacero Bello A, Kim D, Kim D, Park H, Lee S-H. Engineering and functionalization of gelatin biomaterials: from cell culture to medical applications. Tissue Eng. 2020;26:164–80. - PubMed
    1. Boucherit N, Gorvel L, Olive D. 3D tumor models and their use for the testing of immunotherapies. Front Immunol. 2020;11:603640. - PMC - PubMed
    1. Centenera MM, Hickey TE, Jindal S, Ryan NK, Ravindranathan P, Mohammed H, et al. A patient-derived explant (PDE) model of hormone-dependent cancer. Mol Oncol. 2018;12:1608–22. - PMC - PubMed

LinkOut - more resources